NeoGenomics share price logo

NeoGenomics

NASDAQ: NEO

$17.64

+0.08

(+0.47%)

as on

NeoGenomics Stock Performance

as on September 10, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $17.22
    $17.99
    downward going graph

    2.38%

    Downside

    1.98%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.07
    $19.76
    downward going graph

    59.95%

    Downside

    12.02%

    Upside

    downward going graph

NeoGenomics share price movements today

Previous Close
$17.56
Open
$17.30
Volume
955.7K
Market Cap
$2.2B
Day's Low - High
$17.22 - $17.99
52 Week Low - High
$7.07 - $19.76

NeoGenomics Historical Returns

1 Month Return
+ 5.97 %
3 Month Return
+ 53.5 %
1 Year Return
+ 123.41 %
3 Year Return
+ 29.21 %
5 Year Return
-65.78 %

NeoGenomics Stock Fundamentals & Key Indicators

Check NeoGenomics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.2B

EPS (TTM)

-1.98

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.31%

PE Ratio (TTM)

-8.85

Industry PE ratio

49.03

PEG Ratio

-0.16640238911138389

EBITDA

12.9M

Revenue (TTM)

766.3M

Profit Margin

42.92%

Return On Equity TTM

-6.31%

NeoGenomics Stock Valuation

Track how NeoGenomics P/E has moved over time to understand its valuation trends.

NeoGenomics in the last 5 years

  • Overview

  • Trends

Lowest (-98.07x)

December 31, 2021

Today (-2.80x)

December 31, 2025

Industry (49.03x)

December 31, 2025

Highest (-1.59x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -2.80x

NeoGenomics stock Key Stats

Compare market cap, revenue, PE, and other key metrics of NeoGenomics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NeoGenomics image
NeoGenomics
BUY$2.2B-65.78%-8.8542.92%NA

Stock Returns calculator for NeoGenomics Stock including INR - Dollar returns

The NeoGenomics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

NeoGenomics investment value today

Current value as on today

₹2,41,866

Returns

₹1,41,866

(+141.87%)

Returns from NeoGenomics Stock

₹1,24,427 (+124.43%)

Dollar Impact

₹17,438 (+17.44%)

Analyst Recommendation on NeoGenomics Stock

Based on 8 analysts

BUY

62.50%

Buy

37.50%

Hold

0.00%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'BUY' rating for NeoGenomics. Average target price of $19.72

NeoGenomics Share Price Target

Get share price movements and forecasts by analysts on NeoGenomics.

What analysts predicted

10.55%UPSIDE

Target Price

$19.72

Current Price

$17.64

Analyzed by

8 Analysts

Target

$19.72

NeoGenomics target price $19.72, a slight upside of 10.55% compared to current price of $17.64. According to 8 analysts rating.

Indian Investors' Interest in NeoGenomics Stock

Search interest for NeoGenomics Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-8% versus previous 30 day period

NeoGenomics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
156
164
167
172
168
181
187
190
186
201
Gross Profit
65
72
74
77
73
77
80
75
80
91
Operating Income
-30
-21
-21
-18
-27
-47
-27
-11
-18
-9
EBITDA
-7
0
1
3
-6
-27
-9
4
0
18
Interest Expense
1
1
1
1
1
0
0
0
0
0
Depreciation
18
18
17
18
17
17
16
16
16
16
Income Before Tax
-27
-19
-17
-16
-25
-45
-26
-12
-17
1
Income Tax Expense
0
0
0
0
0
0
0
-2
0
0
Net Income
-27
-18
-17
-15
-25
-45
-27
-9
-17
2
Net Profit Margin
41.90%
44.07%
44.62%
44.92%
43.59%
42.61%
42.84%
39.81%
43.32%
45.56%

NeoGenomics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
240
276
408
444
484
509
591
660
727
Gross Profit
101
127
196
185
187
187
244
290
282
Operating Income
2
10
13
-13
-118
-157
-107
-92
-66
EBITDA
26
31
37
34
46
-82
-17
-1
-38
Interest Expense
5
6
3
7
8
7
6
6
3
Depreciation
22
21
30
41
53
69
72
72
67
Income Before Tax
-2
3
3
-14
-15
-159
-97
-80
-110
Income Tax Expense
-2
1
-4
-18
-6
-15
-9
-1
-2
Net Income
0
2
8
4
-8
-144
-87
-78
-108
Net Profit Margin
42.44%
45.99%
48.15%
41.83%
38.62%
36.86%
41.34%
43.92%
38.85%

NeoGenomics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-27
-18
-17
-15
-25
-45
-27
-9
-17
2
Operating Cash Flow
-25
13
9
9
-25
20
8
1
-8
19
Investing Cash Flow
14
7
-3
-5
3
-9
0
-6
-5
-8
Financing Cash Flow
0
1
1
0
0
-202
0
0
0
-12
Change in Cash
-10
23
6
5
-20
-191
9
-4
-13
0

NeoGenomics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
2
8
4
-8
-144
-87
-78
-108
Operating Cash Flow
18
44
23
1
-26
-65
-1
7
5
Investing Cash Flow
-13
-139
-19
-159
-632
0
76
12
-12
Financing Cash Flow
-4
91
159
235
725
11
4
4
-200
Change in Cash
0
-3
163
77
66
-53
79
24
-207

Mutual Funds that own NeoGenomics Stock

Check out the Mutual Funds with significant holdings in NeoGenomics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
7.934942%
10194451
Delaware Group Equity Funds V
7.405531%
9514288
Fidelity Salem Street Trust
1.128675%
1450071
Fidelity Concord Street Trust
1.019934%
1310365
GLENMEDE FUND INC
0.900379%
1156767
See all

Global Institutional Holdings in NeoGenomics

Funds
Holdings
iShares
11.72%
Vanguard
9.63%
First Trust
5.77%
James E. Flynn
3.46%
SPDR
2.21%
See all

NeoGenomics News & Key Events

  • img

    Today's Timeline - 16 October

    Thu, 11:35 AM

    -

    NeoGenomics shares climbed over 8% this week, reflecting renewed investor interest amid long-term challenges.

    Thu, 01:24 PM

    -

    NeoGenomics shares rose 6.3% to $9.97, driven by positive investor expectations and upcoming clinical data presentations.

Insights on NeoGenomics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -17.10M → 2.23M (in $), with an average increase of 864.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NEO stock has moved up by 26.8%

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NEO stock has moved up by 53.5%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NEO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 186.67M → 201.65M (in $), with an average increase of 7.4% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 52.97% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 498.0% return, outperforming this stock by 468.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 47.03% of holdings in Mar 2026 quarter

About NeoGenomics

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
OrganisationNeoGenomics
Headquarters9490 NeoGenomics Way, Fort Myers, FL, United States, 33912
IndustryDiagnostics & Research
CEOMr. Anthony P. Zook
E-voting on sharesClick here to vote

Key Management of NeoGenomics

Name

Title

Mr. Anthony P. Zook

CEO & Director

Ms. Alicia C. Olivo

Executive VP of Business Development & General Counsel

Mr. Gregory D. Aunan

Senior VP & Chief Accounting Officer

Mr. Andrew Frederick Brackmann C.F.A.

Vice President of Investor Relations

Mr. Warren Stone

President & COO

Ms. Elizabeth A. Floegel

Chief Digital & Information Officer

Mr. Gary Passman

Chief People & Culture Officer

Mr. Abhishek Jain

Executive VP & CFO

Mr. Clarence Cooper Esq.

Vice President of Compliance & Privacy

Dr. Andrew A. Lukowiak Ph.D.

Chief Innovation Officer

FAQs

What is NeoGenomics share price today?

NeoGenomics share price today is $17.64 as on at the close of the market. NeoGenomics share today touched a day high of $17.99 and a low of $17.22.

What is the 52 week high and 52 week low for NeoGenomics share?

NeoGenomics share touched a 52 week high of $19.76 on and a 52 week low of $7.07 on . NeoGenomics stock price today i.e. is closed at $17.64,which is 10.73% down from its 52 week high and 149.68% up from its 52 week low.

What is NeoGenomics's market capitalisation today?

NeoGenomics market capitalisation is $0.00T as on .

How to invest in NeoGenomics Stock (NEO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NeoGenomics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NeoGenomics Shares that will get you 0.0850 shares as per NeoGenomics share price of $17.64 per share as on September 10, 2026 at 1:29 am IST.

What is the minimum amount required to buy NeoGenomics Stock (NEO) from India?

Indian investors can start investing in NeoGenomics (NEO) shares with as little as ₹95.105 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.05 in NeoGenomics stock (as per the Rupee-Dollar exchange rate as on ). Based on NeoGenomics share’s latest price of $17.64 as on September 10, 2026 at 1:29 am IST, you will get 0.5669 shares of NeoGenomics. Learn more about fractional shares .

What are the returns that NeoGenomics has given to Indian investors in the last 5 years?

NeoGenomics stock has given -65.78% share price returns and 28.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?